Indications and uses
cures most jock itch relieves itching, burning, cracking, and scaling which accompany this condition
cures most jock itch relieves itching, burning, cracking, and scaling which accompany this condition
adults and children 12 years and over: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying apply once a day to affected skin for 2 weeks or as directed by a doctor wash hands after each use children under 12 years: ask a doctor
do not use if seal on tube is broken or not visible store between 20° to 25°C (68° to 77°F)
Drug Facts
Butenafine hydrochloride 1%
Antifungal
For external use only
When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.
Stop use and ask a doctor if too much irritation occurs or irritation gets worse
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
benzyl alcohol, cetyl alcohol, glycerin, glyceryl monostearate SE, polyoxyethylene (23) cetyl ether, propylene glycol dicaprylate, purified water, sodium benzoate, stearic acid, trolamine, white petrolatum
Distributed by Bayer HealthCare LLC, Whippany, NJ 07981
LOTRIMIN ULTRA®
butenafine hydrochloride cream 1% ANTIFUNGAL NET WT 12g (0.42 OZ)
| Class | Version | Type | Effective |
|---|---|---|---|
| BUTENAFINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0000000000000 | GTIN-13: 0000000000000 EAN-13: 0000000000000 GTIN-12: 000000000000 UPC-A: 000000000000 GTIN storage (14 digits): 00000000000000 | Lotrimin Ultra JI_4339.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-4339-1 | Lotrimin UltraJock Itch | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 11523-4339-1 | Lotrimin UltraJock Itch | 12 g in 1 TUBE | CREAM | 12 | 9 | |
| 11523-4339-2 | Lotrimin UltraJock Itch | 15 g in 1 TUBE | CREAM | 15 | 9 | |
| 11523-4339-2 | Lotrimin UltraJock Itch | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 11523-4339-3 | Lotrimin UltraJock Itch | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 11523-4339-3 | Lotrimin UltraJock Itch | 30 g in 1 TUBE | CREAM | 30 | 9 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-4339-1 | GM - Gram | 11523-4339 | 161280fc-9a5a-40b8-afc5-a82e15a43e72 | 1 | 2017-06-15 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Butenafine hydrochloride | ACTIVE INGREDIENT | R8XA2029ZI | 1 | |
| Butenafine | ACTIVE MOIETY | 91Y494NL0X | 1 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| ceteth-23 | INACTIVE INGREDIENT | 495CTZ441V | 1 | |
| cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| propylene glycol dicaprylate | INACTIVE INGREDIENT | 581437HWX2 | 1 | |
| sodium benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| trolamine | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11523-4339 | 11523-4339-1, 11523-4339-2, 11523-4339-3 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CETYL ALCOHOL | 936JST6JCN | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| CETETH-23 | 495CTZ441V | IACT |
| PROPYLENE GLYCOL DICAPRYLATE | 581437HWX2 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TROLAMINE | 9O3K93S3TK | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| BUTENAFINE HYDROCHLORIDE | R8XA2029ZI | ACTIB |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1800 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 36 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 360 mg | ||
| ceteth-23 | CETETH-23 | 495CTZ441V | CREAM / TOPICAL | 240 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 24 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 24 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 360 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| propylene glycol dicaprylate | PROPYLENE GLYCOL DICAPRYLATE | 581437HWX2 | CREAM / TOPICAL | 1200 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 36 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1800 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 36 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 24 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 36 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 360 mg | ||
| ceteth-23 | CETETH-23 | 495CTZ441V | CREAM / TOPICAL | 240 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 24 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1800 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| ceteth-23 | CETETH-23 | 495CTZ441V | CREAM / TOPICAL | 240 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| propylene glycol dicaprylate | PROPYLENE GLYCOL DICAPRYLATE | 581437HWX2 | CREAM / TOPICAL | 1200 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 360 mg | ||
| propylene glycol dicaprylate | PROPYLENE GLYCOL DICAPRYLATE | 581437HWX2 | CREAM / TOPICAL | 1200 mg | ||
| propylene glycol dicaprylate | PROPYLENE GLYCOL DICAPRYLATE | 581437HWX2 | CREAM / TOPICAL | 1200 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1800 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| ceteth-23 | CETETH-23 | 495CTZ441V | CREAM / TOPICAL | 240 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021307-001 | LOTRIMIN ULTRA | BUTENAFINE HYDROCHLORIDE | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3bdfa0b2c4d7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lotrimin Ultra Jock Itch | BUTENAFINE HYDROCHLORIDE | Bayer Healthcare LLC. | 9dfa08fb-0913-4326-b1eb-1425df6a2c82 | 2025-12-05 | Warnings | 11523-4339-1 11523-4339-2 11523-4339-3 11523-4339 11523433901 11523433903 11523433902 45370735-3f9d-a7f8-e063-6294a90aa0c6 9dfa08fb-0913-4326-b1eb-1425df6a2c82 |
Adverse event summaries are temporarily unavailable. Other product information remains available.